Skip to content

Effect of Smoking on Ventilation-Perfusion Ratio

Acute Effect of Smoking Cigarettes on Ventilation-Perfusion Ratio: A Pilot Study in Healthy Volunteers

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02963467
Enrollment
20
Registered
2016-11-15
Start date
2018-09-17
Completion date
2019-09-30
Last updated
2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Disease

Keywords

multiple inert gas elimination technique, smoking, pulmonary disorder

Brief summary

Smoking is one of the world's leading health hazards. Besides being a major risk factor in the etiology of COPD and lung cancer, cigarette smoke is also a causative agent lung diseases characterized by bronchiolar and interstitial inflammation. However, the associated lung pathology of smoking is not only a risk in the development of lung diseases, but also widely recognized as a major risk factor associated with perioperative respiratory and cardiovascular complications. Apart from the long term effects of cigarette smoke, acute effects of the inhalation of cigarettes smoke may influence the course of lung pathology. The inhalation of smoke causes inflammation in the lung by inducing chemotaxis and activation of neutrophils and macrophages and induces oxidative stress. As the acute inflammatory response to smoke inhalation seems to be the underlying mechanism for chronic diseases of smokers, exploring the field of the acute pulmonary changes after exposure to cigarette smoke is highly relevant. One reason for acute hypoxia and injury during smoking might be a severe mismatch of ventilation and perfusion of the lung. Using the multiple inert gas elimination technique (MIGET), a distribution of ventilation-perfusion ratios in the lung can be calculated by analyzing data on the retention and excretion of six infused inert gases. A saline solution containing the gases is infused intravenously. When passing through the lung the gases are either eliminated from the blood or retained depending on their partition coefficient and local V/Q ratio. The concentrations of the gases are measured in the mixed venous blood or the mixed expired gas and the arterial blood allowing for the calculation of retention and excretion and the derivation of V/Q distribution. MIGET is the experimental gold standard to determine the Ventilation-Perfusion ratio of the lung. The aim of this study is to show the acute effect of smoking on ventilation/perfusion ratio distribution in the lung in otherwise healthy smokers.

Interventions

PROCEDUREcigarette

smoking 4 conventional cigarettes

PROCEDUREdummy cigarette

smoking a dummy cigarette

Sponsors

Medical University of Vienna
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* normal body mass index (BMI)

Exclusion criteria

* Medical history of pulmonary or cardiovascular disease * Family history of malignant hyperthermia, neuro-muscular disorders * Known hypersensitivity to any of the inert gases or substances administered * History of post operative nausea and vomiting * Pregnancy (pregnancy test will be performed on study day)

Design outcomes

Primary

MeasureTime frameDescription
ventilation-perfusion ratio by MMIMS-MIGETwithin a time-frame of 6 hoursV/Q-ratio as well as shunt, low V/Q, normal V/Q and high V/Q i.e. deadspace will be assessed by micropore-membrane inlet mass-spectrometry multiple inert gas elimination technique (MMIMS-MIGET)

Secondary

MeasureTime frameDescription
serum nicotine by blood samplingwithin a time-frame of 6 hoursthe serum nicotine level will be assessed by clinical chemistry

Countries

Austria

Contacts

Primary ContactStefan Boehme, Ass.-Prof. Dr.
stefan.boehme@meduniwien.ac.at00436766767144

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026